| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,615,431 ) |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R25DK122952 | Diabetes Institute Summer Interprofessional Research Experience (DISIRE) for Undergraduates | 000 | 2 | NIH | 1/23/2024 | $95,655 |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01DK138635 | Identifying a novel player in skeletal muscle performance and metabolism | 000 | 1 | NIH | 3/18/2024 | $596,639 |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R21HD108761 | A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model | 000 | 2 | NIH | 3/19/2024 | $139,862 |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R03NS137135 | Inhibiting Adrenomedullin signaling to prevent mammalian brain endothelial cell abnormalities and brain arteriovenous malformation | 000 | 1 | NIH | 2/19/2024 | $75,500 |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AG067758 | Motoneuronal mechanisms underlying age-related muscle weakness | 000 | 4 | NIH | 3/14/2024 | $520,185 |
| | 2024 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AG059779 | Combining GHR antagonism with life extending compounds: a search for synergies | 000 | 7 | NIH | 4/22/2024 | $625,013 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R03HS029407 | Primary Care Needs for Patients with Vascular Anomalies: Improving Continuity of Care and Care Coordination in Rare Diseases | 000 | 1 | AHRQ | 10/13/2023 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 03 | 2 | HRSA | 4/5/2024 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 02 | 2 | HRSA | 4/4/2024 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 01 | 2 | HRSA | 12/15/2023 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 02 | 4 | HRSA | 2/14/2024 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 02 | 4 | HRSA | 2/14/2024 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 01 | 4 | HRSA | 12/15/2023 | $0 |
| | 2024 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 01 | 4 | HRSA | 12/15/2023 | $0 |
| | 2024 | 2022 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | CE147148 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R15MH128703 | Fear, gastrointestinal distress, and interoception: Physiological and psychological mechanisms in eating disorders | 000 | 1 | NIH | 4/9/2024 | $0 |
| | 2024 | 2021 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R15GM110602 | Novel Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Therapeutic Agents | 000 | 2 | NIH | 3/26/2024 | $0 |
| | 2024 | 2020 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15NS115080 | Effect of zinc on tPA induced thrombolysis | 000 | 1 | NIH | 3/6/2024 | -$9,085 |
| | 2024 | 2020 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15HD101984 | Ontogeny of the pre-pharyngeal swallow: effect of dietary texture-modification on the development of tongue kinematics and performance | 000 | 1 | NIH | 12/27/2023 | $0 |
| | 2024 | 2019 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T9833468 | Opioid Workforce Expansion Program- Professional | 03 | 1 | HRSA | 3/8/2024 | -$421,637 |
| | 2024 | 2019 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15DC017616 | Effect of Sensorineural Hearing Loss on the Neural Coding of Spatial Hearing | 000 | 1 | NIH | 10/23/2023 | $0 |
| | 2024 | 2019 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15NS111376 | Effects on perivascular cells during Notch mediated brain arteriovenous malformation | 000 | 1 | NIH | 1/5/2024 | $0 |
| | 2024 | 2019 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15MH116311 | A Novel Approach to Integrating Event-Related Potentials and Self-Report Indices of Transdiagnostic Risk Factors of Emotional Distress | 000 | 1 | NIH | 12/14/2023 | -$6,531 |
| | 2024 | 2019 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15DK121247 | Reducing Glycolytic Activity to Restore Normal Islet Glucose Sensing in Early Type 2 Diabetes | 000 | 1 | NIH | 12/14/2023 | -$170 |
|
| Issue Date FY: 2023 ( Subtotal = $8,621,123 ) (Continued on the next page) |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AI143743 | Post-translational regulation of alpha PSM production in Staphylococcus aureus by the small RNA Teg41 | 000 | 5 | NIH | 7/14/2023 | $410,424 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01MD012579 | Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics | 001 | 5 | NIH | 2/6/2023 | $56,449 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R15AG073922 | Investigating the relationship between age-related skeletal muscle insulin resistance and cognitive impairment | 000 | 1 | NIH | 3/21/2023 | $323,788 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R15HG009972 | Super-Resolution Optical Mapping for DNA Analysis Using Triplex-Forming Oligonucleotides as Stochastic Molecular Probes | 001 | 2 | NIH | 4/26/2023 | $448,094 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AG059779 | Combining GHR antagonism with life extending compounds: a search for synergies | 000 | 6 | NIH | 7/26/2023 | $628,088 |
| | 2023 | 2023 | Ohio University | 1 Ohio University | Athens | OH | 45701-2942 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 00 | 12 | CDC | 6/7/2023 | $22,378 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 00 | 4 | HRSA | 8/10/2023 | $286,813 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 00 | 4 | HRSA | 8/10/2023 | $47,230 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | E3717290 | LDS - Osteopathic Medicine | 000 | 2 | HRSA | 8/22/2023 | $29,884 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R03AG081950 | Role of Keratin 18 for Stress-induced Adaptive Strength Gains | 000 | 1 | NIH | 9/22/2023 | $151,000 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R21AG081962 | Developing helical peptide antagonists of the growth hormone receptor | 000 | 1 | NIH | 9/20/2023 | $415,250 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AG078129 | Neural mechanisms of age-related weakness | 000 | 1 | NIH | 8/10/2023 | $650,453 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R15GM132841 | R15 AREA: Optimizing allosteric modulation of noncoding regulatory RNA function | 000 | 2 | NIH | 9/8/2023 | $453,000 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R03HS029407 | Primary Care Needs for Patients with Vascular Anomalies: Improving Continuity of Care and Care Coordination in Rare Diseases | 000 | 1 | AHRQ | 9/14/2023 | $49,641 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R21HD108761 | A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model | 000 | 1 | NIH | 3/17/2023 | $268,566 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AR081804 | Growth hormone regulating chondrocyte metabolism for osteoarthritis development | 000 | 1 | NIH | 7/3/2023 | $501,950 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R13AI176858 | Wind River Conference on Prokaryotic Biology | 000 | 1 | NIH | 2/28/2023 | $7,000 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 Ohio University | Athens | OH | 45701-2942 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 00 | 2 | HRSA | 7/24/2023 | $500,000 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R21NS130256 | Activity-dependent release of human alpha-synuclein | 001 | 1 | NIH | 3/6/2023 | $0 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R21NS130256 | Activity-dependent release of human alpha-synuclein | 000 | 1 | NIH | 2/1/2023 | $403,010 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01ES030425 | Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses | 000 | 5 | NIH | 4/13/2023 | $339,750 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R01AR077248 | Discovery of the Neural Drivers Underlying Injury-Risk Biomechanics | 000 | 3 | NIH | 2/16/2023 | $155,407 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R34DA055228 | Developing Implementation Strategies to Improve Access to Transitional Opioid Programs in Safety Net Hospitals | 000 | 2 | NIH | 6/7/2023 | $234,568 |
| | 2023 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2942 | ATHENS | USA | R34DA057160 | Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing among Rural Primary Care Providers in Ohio | 000 | 2 | NIH | 6/9/2023 | $228,270 |
|
